Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heska Corp (NASDAQ:HSKA)

33.49
Delayed Data
As of Aug 27
 -0.66 / -1.93%
Today’s Change
11.89
Today|||52-Week Range
35.63
+84.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$223.1M

Company Description

Heska Corp. develops, manufacture, market, sell and support veterinary products. The company focuses on the canine and feline companion animal health markets. It operates its business through two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment includes primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The Other Vaccines, Pharmaceuticals and Products segment includes private label vaccine and pharmaceuticals, primarily for cattle as well as for other animals, including small mammals. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Contact Information

Heska Corp.
3760 Rocky Mountain Avenue
Loveland Colorado 80538
P:(970) 493-7272
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Kevin S. WilsonPresident, Chief Executive Officer & Director
Jason A. NapolitanoChief Financial Officer, Secretary & Executive VP
Laurie E. PetersonVice President-Technical Operations
Nancy WisnewskiEVP-Product Development & Customer Support
Michael J. McGinleyPresident-Biologicals & Pharmaceuticals